Rajagukguk RM. USE OF SODIUM-GLUCOSE TRANSPORT PROTEIN 2 (SGLT2) INHIBITORS IN DIABETIC KIDNEY DISEASE (DKD). JARMHS [Internet]. 2023 Apr. 28 [cited 2024 Nov. 24];9(4):46-52. Available from: https://jarmhs.com/MHS/index.php/mhs/article/view/168